ArticleIntestinal research2022

Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study.

Seung Yong Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.